2008European Surgical ResearchRequires access

Immunofluorescent Titration of Thymocyte Reactive Membrane Antibodies as a Suggested in vitro Correlate of the Immunosuppressive Potency of Anti-Human Thymocyte Globulin

Richard J. Ablin, R. Morrell

Open publisher page 1 citations

Abstract

Continued utilization of antilymphocyte and antithymocyte sera for clinical use as an immunosuppressant emphasizes the need for a reproducible in vitro assay that will correlate closely with graft protection in vivo. In this regard the in vitro serologic reactivity of antibodies in three preparations of horse anti-human thymocyte globulin (HAHTG) to cell surface antigens of human thymocytes (thymic lymphocytes) as determined by agglutination, cytotoxicity and in particular for the present study by immunofluorescence (IF) have been compared with their in vivo immunosuppressive potency as measured by prolongation of graft survival. Titration by IF of antibodies in HAHTG reactive with surface antigens of cells of the thymolymphatic system appeared to provide a reasonably simple, reliable and complement-independent in vitro correlate of immunosuppressive potency.

About this research paper

What this paper is about

Continued utilization of antilymphocyte and antithymocyte sera for clinical use as an immunosuppressant emphasizes the need for a reproducible in vitro assay that will correlate closely with graft protection in vivo. In this regard the in vitro serologic reactivity of antibodies in three preparations of horse anti-human thymocyte globulin (HAHTG) to cell surface antigens of human thymocytes (thymic lymphocytes) as determined by agglutination, cytotoxicity and in particular for the present study by immunofluorescence (IF) have been compared with their in vivo immunosuppressive potency as measured by prolongation of graft survival. Titration by IF of antibodies in HAHTG reactive with surface antigens of cells of the thymolymphatic system appeared to provide a reasonably simple, reliable and complement-independent in vitro correlate of immunosuppressive potency.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Continued utilization of antilymphocyte and antithymocyte sera for clinical use as an immunosuppressant emphasizes the need for a reproducible in vitro assay that will correlate closely with graft protection in vivo. In this regard the in vitro serologic reactivity of antibodies in three preparations of horse anti-human thymocyte globulin (HAHTG) to cell surface antigens of human thymocytes (thymic lymphocytes) as determined by agglutination, cytotoxicity and in particular for the present study by immunofluorescence (IF) have been compared with their in vivo immunosuppressive potency as measured by prolongation of graft survival. Titration by IF of antibodies in HAHTG reactive with surface antigens of cells of the thymolymphatic system appeared to provide a reasonably simple, reliable and complement-independent in vitro correlate of immunosuppressive potency.

Key concepts: Thymocyte, Anti-thymocyte globulin, Potency, In vivo, In vitro, Antibody, Antigen, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Immunofluorescent Titration of Thymocyte Reactive Membrane Antibodies as a Suggested in vitro Correlate of the Immunosuppressive Potency of Anti-Human Thymocyte Globulin — Research Paper | ScholarLens